D. Solomon

发表

The Bethesda system for reporting cervical cytology : definitions, criteria, and explanatory notes

D. Solomon, R. Nayar, Diane Solomon, 2004 .

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

M. Schiffman, A. Moscicki, D. Solomon, 2012, CA: a cancer journal for clinicians.

Interim Guidelines for Management of Abnormal Cervical Cytology

E. Trimble, M. Schiffman, L. Twiggs, 1994 .

PAPNET analysis of reportedly negative smears preceding the diagnosis of a high-grade squamous intraepithelial lesion or carcinoma.

L. Mango, M. Sherman, M. Schiffman, 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

The Bethesda System for Reporting Cervical Cytology

Diane Solomon, David C. Wilbur, D. Solomon, 2004 .

Interleukin-10 in the vitreous of patients with primary intraocular lymphoma.

D. Solomon, R. Nussenblatt, C. Chan, 1995, American journal of ophthalmology.

Evaluation of the Polyclonal ELISA HPV Serology Assay as a Biomarker for Human Papillomavirus Exposure

L. Dodd, S. Wacholder, M. Sherman, 2011, Sexually transmitted diseases.

Determinants of human papillomavirus‐negative, low‐grade squamous intraepithelial lesions in the atypical squamous cells of undetermined significance/low‐grade squamous intraepithelial lesions triage study (ALTS)

M. Schiffman, D. Solomon, R. Zuna, 2005, Cancer.

Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study.

M. Schiffman, D. Solomon, R. Guido, 2003, American journal of obstetrics and gynecology.

Evaluating the Risk of Cervical Precancer with a Combination of Cytologic, Virologic, and Visual Methods

M. Schiffman, D. Solomon, Joan L. Walker, 2005, Cancer Epidemiology Biomarkers & Prevention.

Stability of archived liquid‐based cervical cytologic specimens

Diane Solomon, Mark Schiffman, Allan Hildesheim, 2003, Cancer.

Interlaboratory reliability of Hybrid Capture 2.

C. Peyton, C. Wheeler, M. Schiffman, 2004, American journal of clinical pathology.

RESPONSE: Re: A Study of the Impact of Adding HPV Types to Cervical Cancer Screening and Triage Tests

C. Wheeler, M. Schiffman, D. Solomon, 2005 .

Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy.

J. T. Cox, M. Schiffman, D. Solomon, 2003, American journal of obstetrics and gynecology.

Support from authors of the Bethesda system

D. Solomon, R. Nayar, 2008, Cytopathology : official journal of the British Society for Clinical Cytology.

A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia.

R. DeSalle, S. Wacholder, Kai Yu, 2010, Cancer research.

Human Papillomavirus Genotype Specificity of Hybrid Capture 2

C. Wheeler, S. Wacholder, M. Schiffman, 2008, Journal of Clinical Microbiology.

Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial.

D. Lowy, S. Wacholder, W. Quint, 2011, The Lancet. Oncology.

American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer

A. Moscicki, D. Solomon, D. Saslow, 2002, CA: a cancer journal for clinicians.

Statement on human papillomavirus DNA test utilization.

D. Solomon, D. Davey, J. Papillo, 2009, Archives of pathology & laboratory medicine.

Statement on HPV DNA test utilization

D. Solomon, D. Davey, J. Papillo, 2009, Diagnostic cytopathology.

Statement on human papillomavirus DNA test utilization

D. Solomon, D. Davey, J. Papillo, 2009, Cancer.

Statement on HPV DNA test utilization.

D. Solomon, J. Papillo, Diane Davis Davey, 2009, Journal of lower genital tract disease.

Statement on HPV DNA test utilization.

D. Solomon, D. Davey, J. Papillo, 2009, American journal of clinical pathology.

Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS).

J. T. Cox, W. Lawrence, C. Wheeler, 2006, Journal of the National Cancer Institute.

A Comparison of Linear Array and Hybrid Capture 2 for Detection of Carcinogenic Human Papillomavirus and Cervical Precancer in ASCUS-LSIL Triage Study

C. Wheeler, M. Schiffman, D. Solomon, 2008, Cancer Epidemiology Biomarkers & Prevention.

Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine

D. Lowy, S. Wacholder, M. Sherman, 2011, Journal of the National Cancer Institute.

Screening and prevention methods for cervical cancer.

M. Schiffman, D. Solomon, 2009, JAMA.

Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS).

M. Schiffman, D. Solomon, Joan L. Walker, 2006, American journal of obstetrics and gynecology.

A comparison of a prototype PCR assay and hybrid capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal papanicolaou smears.

C. Wheeler, M. Schiffman, D. Solomon, 2005, American journal of clinical pathology.

Seroprevalence and Correlates of Human Papillomavirus 16/18 Seropositivity Among Young Women in Costa Rica

S. Wacholder, M. Sherman, W. Quint, 2010, Sexually transmitted diseases.

Pitfalls in diagnostic cervicovaginal cytology.

D. Solomon, M. Sidawy, 1997, Monographs in pathology.

Can HPV-16 genotyping provide a benchmark for cervical biopsy specimen interpretation?

M. Schiffman, D. Solomon, M. Stoler, 2008, American journal of clinical pathology.

Scientific issues related to the cytology proficiency testing regulations

Brenda L. Schultz, M. Bibbo, L. Howell, 2006, Acta Cytologica.

Have we resolved how to triage equivocal cervical cytology?

M. Schiffman, D. Solomon, 2004, Journal of the National Cancer Institute.

ASCUS LSIL Triage Study (ALTS) Conclusions Reaffirmed: Response to a November 2001 Commentary

M. Schiffman, R. Tarone, D. Solomon, 2002, Obstetrics and gynecology.

Qualification of ASCUS. A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study.

M. Sherman, M. Schiffman, D. Solomon, 2001, American journal of clinical pathology.

Diagnostic Utility of Endocervical Curettage in Women Undergoing Colposcopy for Equivocal or Low-Grade Cytologic Abnormalities

M. Schiffman, D. Solomon, M. Stoler, 2007, Obstetrics and gynecology.

Proposed guidelines for primary screening instruments for gynecologic cytology. Developed by the Intersociety Working Group for Cytology Technologies.

P. Saigo, I. Ramzy, S. Raab, 1997, Acta cytologica.

Tumor-infiltrating lymphocytes from nonrenal urological malignancies

G. Haas, S. Rosenberg, D. Solomon, 2005, Cancer Immunology, Immunotherapy.

Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma

D. Solomon, Chi-Chao Chan, M. D. de Smet, 1999, The British journal of ophthalmology.

Diagnosis of pulmonary microvascular metastases by cytologic evaluation of pulmonary artery catheter-derived blood specimens.

D. Solomon, R. Danner, A. Abati, 1994, Human pathology.

Evidence that Taking More Cervical Biopsies Substantially Improves the Sensitivity of Colposcopically Guided Biopsies

M. Schiffman, D. Solomon, J. Gage, 2006 .

A Study of Amplicor Human Papillomavirus DNA Detection in the Atypical Squamous Cells of Undetermined Significance–Low-Grade Squamous Intraepithelial Lesion Triage Study

C. Wheeler, D. Solomon, P. Castle, 2009, Cancer Epidemiology Biomarkers & Prevention.

Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma.

R. Wittes, D. Solomon, R. Nussenblatt, 1997, Archives of ophthalmology.

Immunocytochemical staining of vitreous cells. Indications, techniques, and results.

D. Solomon, R. Nussenblatt, A. Palestine, 1992, Ophthalmology.

The 1988 Bethesda system for reporting cervical/vaginal cytologic diagnoses: developed and approved at a National Cancer Institute workshop, Bethesda MD, U.S.A., December 12-13, 1988

D. Solomon, D. Solomon, 1989 .

Prevalence of and risk factors for anal human papillomavirus infection among young healthy women in Costa Rica.

D. Lowy, S. Wacholder, W. Quint, 2012, The Journal of infectious diseases.

Second edition of 'The Bethesda System for reporting cervical cytology' – atlas, website, and Bethesda interobserver reproducibility project

D. Solomon, R. Nayar, 2004, CytoJournal.

A prospective study of the value of core needle biopsy and fine needle aspiration in the diagnosis of soft tissue masses.

M. Merino, D. Solomon, R. Barth, 1992, Surgery.

Ultrasound-guided fine-needle aspiration of parathyroid lesions: a morphological and immunocytochemical approach.

D. Solomon, M. Skarulis, A. Abati, 1995, Human pathology.

Tumor-infiltrating lymphocytes. Cytologic, phenotypic and morphometric analysis.

D. Solomon, J. Yannelli, G. Oliver, 1996, Acta cytologica.

Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS).

W. Lawrence, M. Schiffman, J. Mandelblatt, 2006, Journal of the National Cancer Institute.

HPV vaccination in women aged 24–45 years

S. Wacholder, D. Solomon, P. Castle, 2009, The Lancet.

A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study (Cancer Epidemiology Biomarkers and Prevention (2009) 18, 1, (1341-9))

C. Wheeler, D. Solomon, P. Castle, 2009 .

Renal pathology in von Hippel-Lindau disease.

D. Solomon, A. Schwartz, Arnold M. Schwartz, 1988, Human pathology.

Number of Cervical Biopsies and Sensitivity of Colposcopy

Diane Solomon, Mark Schiffman, Jose Jeronimo, 2006, Obstetrics and gynecology.

Assessing the Burden of HPV-Associated Cancers in the United States

M. Schiffman, D. Solomon, D. Saslow, 2008 .

Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.

Diane Solomon, Allan Hildesheim, Sholom Wacholder, 2010, Journal of the National Cancer Institute.

Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study

S. Wacholder, M. Sherman, D. Solomon, 2009, BMJ : British Medical Journal.

The distribution of neoplasia arising on the cervix: results from the ALTS trial.

M. Schiffman, D. Solomon, R. Guido, 2005, American journal of obstetrics and gynecology.

Suspicious Violaceous Subungual Nodule

D. Solomon, C. Kauffman, D. Abangan, 1994 .

Suspicious violaceous subungual nodule. Metastatic renal cell carcinoma(RCC).

D. Solomon, C. Kauffman, D. Abangan, 1994, Archives of dermatology.

The carcinogenicity of human papillomavirus types reflects viral evolution.

R. DeSalle, S. Wacholder, M. Sherman, 2005, Virology.

The 2001 Bethesda System: terminology for reporting results of cervical cytology.

Mark Sherman, Ann Moriarty, Dennis O'Connor, 2002, JAMA.

Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica.

D. Lowy, S. Wacholder, W. Quint, 2013, The Journal of infectious diseases.

Solid and Papillary Epithelial Neoplasm of the Pancreas An Ultrastructural and Immunocytochemical Study of Six Cases

M. Lieber, T. Triche, M. Merino, 1987, The American journal of surgical pathology.

Scientific issues related to the cytology proficiency testing regulations.

R. Marshall Austin, Dina R. Mody, George G. Birdsong, 2006, Acta cytologica.

The Bethesda System for reporting cervical/vaginal cytologic diagnoses: revised after the second National Cancer Institute Workshop, April 29-30, 1991.

Diane Solomon, D. Solomon, R. Kurman, 1993, Acta cytologica.

Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica

D. Lowy, S. Wacholder, W. Quint, 2013, PloS one.

Risk estimation for the next generation of prevention programmes for cervical cancer.

S. Wacholder, M. Schiffman, D. Solomon, 2009, The Lancet. Oncology.

2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests.

Diane Solomon, Mark Spitzer, Thomas C Wright, 2007, American journal of obstetrics and gynecology.

Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia–Grade 2

C. Wheeler, M. Schiffman, D. Solomon, 2009, Obstetrics and gynecology.

Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial.

M. Schiffman, R. Tarone, D. Solomon, 2001, Journal of the National Cancer Institute.

Human Papillomavirus Testing Following Loop Electrosurgical Excision Procedure Identifies Women at Risk for Posttreatment Cervical Intraepithelial Neoplasia Grade 2 or 3 Disease

C. Wheeler, S. Wacholder, M. Schiffman, 2006, Cancer Epidemiology Biomarkers & Prevention.

Cytologic detection of esophageal squamous cell carcinoma and precursor lesions using balloon and sponge samplers in asymptomatic adults in Linxian, China

P R Taylor, P. Taylor, S. Dawsey, 1997, Cancer.

Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening

J. T. Cox, M. Schiffman, T. Wright, 2004, Obstetrics and gynecology.

Cell Preparation Methods and Criteria for Sample Adequacy

A. Reith, L. Mango, I. Ramzy, 1998, Acta Cytologica.

CIN2 Is a Much Less Reproducible and Less Valid Diagnosis than CIN3: Results from a Histological Review of Population-Based Cervical Samples

S. Wacholder, M. Sherman, D. Solomon, 2007, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Cervical cancer prevention--cervical screening: science in evolution.

Diane Solomon, Philip E Castle, Mahboobeh Safaeian, 2007, Obstetrics and gynecology clinics of North America.

2006 Consensus Guidelines for the Management of Women With Cervical Intraepithelial Neoplasia or Adenocarcinoma In Situ

Diane Solomon, Mark Spitzer, Thomas C Wright, 2007, Journal of lower genital tract disease.

2006 Consensus Guidelines for the Management of Women With Abnormal Cervical Screening Tests

T. Wright, D. Solomon, M. Spitzer, 2007, Journal of lower genital tract disease.

Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial.

D. Lowy, S. Wacholder, D. Solomon, 2007, JAMA.

Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel-Lindau disease: clinical and molecular genetic implications.

W. Linehan, I. Lubensky, M. Walther, 1995, The Journal of urology.

Human papillomavirus infection and the primary and secondary prevention of cervical cancer

D. Lowy, M. Schiffman, D. Solomon, 2008, Cancer.

Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica.

Diane Solomon, John Schiller, Allan Hildesheim, 2008, Vaccine.

Detection of the von Hippel-Lindau gene deletion in cytologic specimens using microdissection and the polymerase chain reaction.

L. Liotta, M. Emmert-Buck, D. Solomon, 1994, Acta cytologica.

The 2001 Bethesda system: Terminology for reporting results of cervical cytology

M. Sherman, T. Wright, S. Raab, 2002 .

Cervical Cancer Screening Rates in the United States and the Potential Impact of Implementation of Screening Guidelines

D. Solomon, N. Breen, T. McNeel, 2007, CA: a cancer journal for clinicians.

2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.

Diane Solomon, Nicolas Wentzensen, Mark Schiffman, 2013, Obstetrics and gynecology.

Low risk of type‐specific carcinogenic HPV re‐appearance with subsequent cervical intraepithelial neoplasia grade 2/3

S. Wacholder, D. Solomon, R. Burk, 2012, International journal of cancer.

Neither one‐time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancer

S. Wacholder, M. Sherman, D. Solomon, 2009, International journal of cancer.

Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections.

S. Wacholder, D. Solomon, P. Castle, 2008, Journal of the National Cancer Institute.

Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica.

Diane Solomon, Wim Quint, Allan Hildesheim, 2011, Cancer discovery.

2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors

M. Schiffman, M. Einstein, D. Solomon, 2013, Journal of lower genital tract disease.

The impact of human papillomavirus vaccination on cervical cancer prevention efforts.

C. Wheeler, M. Einstein, D. Solomon, 2009, Gynecologic oncology.

2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ.

Diane Solomon, Mark Spitzer, Thomas C Wright, 2007, American journal of obstetrics and gynecology.

The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report.

Diane Solomon, Mark Schiffman, Mark H Stoler, 2007, American journal of clinical pathology.

M. Schiffman, A. Moscicki, D. Solomon, 2012, American journal of clinical pathology.

Comparison of Linear Array and Line Blot Assay for Detection of Human Papillomavirus and Diagnosis of Cervical Precancer and Cancer in the Atypical Squamous Cell of Undetermined Significance and Low-Grade Squamous Intraepithelial Lesion Triage Study

Diane Solomon, Mark Schiffman, Cosette M. Wheeler, 2007, Journal of Clinical Microbiology.

From Papanicolaou to Bethesda: The rationale for a new cervical cytologic classification

D. Solomon, G. Malkasian, R. Kurman, 1991, Obstetrics and gynecology.

Letter to the Editor of Lancet

S. Wacholder, M. Schiffman, D. Solomon, 2009 .

American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer

Diane Solomon, Anna-Barbara Moscicki, A. Moscicki, 2003, Journal of lower genital tract disease.

Cervical cytology of atypical squamous cells–cannot exclude high‐grade squamous intraepithelial lesion (ASC‐H)

D. Solomon, P. Castle, M. Sherman, 2006, Cancer.

Clinical practice. Cervical-cancer screening with human papillomavirus and cytologic cotesting.

Diane Solomon, Mark Schiffman, M. Schiffman, 2013, The New England journal of medicine.

The Bethesda interobserver reproducibility study (BIRST)

Diane Solomon, Mark Schiffman, M. Sherman, 2006, Cancer.

An Analysis of High-Risk Human Papillomavirus DNA-Negative Cervical Precancers in the ASCUS-LSIL Triage Study (ALTS)

J. T. Cox, C. Wheeler, M. Schiffman, 2008, Obstetrics and gynecology.

Findings to date from the ASCUS-LSIL Triage Study (ALTS).

M. Schiffman, D. Solomon, 2003, Archives of pathology & laboratory medicine.

The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses

Diane Solomon, D. Solomon, R. Kurman, 1994, Springer US.

Increasing the accuracy of fine-needle biopsy for thyroid nodules.

D. Solomon, M. Husain, J. Hamburger, 1989, Archives of pathology & laboratory medicine.

Mantle cell lymphoma: A cytopathological and immunocytochemical study

E. Jaffe, D. Solomon, Y. Hijazi, 1996, Diagnostic cytopathology.

A study of the impact of adding HPV types to cervical cancer screening and triage tests.

C. Wheeler, S. Wacholder, M. Schiffman, 2005, Journal of the National Cancer Institute.

Determinants of seropositivity among HPV-16/18 DNA positive young women

S. Wacholder, M. Sherman, M. Schiffman, 2010, BMC infectious diseases.

ASCUS and AGUS Criteria

W. Frable, D. Solomon, D. Wilbur, 1998, Acta Cytologica.

The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses: An Overview

D. Solomon, 1991, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Chapter 14: Role of triage testing in cervical cancer screening.

Diane Solomon, D. Solomon, 2003, Journal of the National Cancer Institute. Monographs.

Role of triage testing in cervical cancer screening

D. Solomon, 2003 .

ASCUS and AGUS criteria. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.

W. Frable, G. Vooijs, D. Solomon, 1998, Acta cytologica.

Screening for cervical cancer: prospects for the future.

D. Solomon, 1993, Journal of the National Cancer Institute.

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer

Evan R. Myers, Eduardo L. Franco, Diane Solomon, 2012, Journal of lower genital tract disease.

The Natural History of Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia Among Young Women in the Guanacaste Cohort Shortly After Initiation of Sexual Life

S. Wacholder, M. Sherman, D. Solomon, 2007, Sexually transmitted diseases.

The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays.

M. Schiffman, D. Solomon, M. Stoler, 2007, American journal of clinical pathology.

Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities.

C. Wheeler, D. Solomon, P. Castle, 2005, Journal of the National Cancer Institute.

Risk assessment to guide the prevention of cervical cancer.

Diane Solomon, Mark Schiffman, Jose Jeronimo, 2007, American journal of obstetrics and gynecology.

Comparison of Measurements of Human Papillomavirus Persistence for Postcolposcopic Surveillance for Cervical Precancerous Lesions

C. Wheeler, M. Schiffman, D. Solomon, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Detection of precancerous cervical lesions is differential by human papillomavirus type.

C. Wheeler, M. Schiffman, D. Solomon, 2009, Cancer research.

Statement on HPV DNA Test Utilization

D. Solomon, D. Davey, J. Papillo, 2009, Acta Cytologica.

Risk of Precancer Determined by HPV Genotype Combinations in Women with Minor Cytologic Abnormalities

C. Wheeler, M. Schiffman, D. Solomon, 2013, Cancer Epidemiology, Biomarkers & Prevention.

Switch from cytology‐based to human papillomavirus test‐based cervical screening: Implications for colposcopy

S. Wacholder, D. Solomon, N. Wentzensen, 2012, International journal of cancer.

Risk of Precancer and Follow-up Management Strategies for Women With Human Papillomavirus–Negative Atypical Squamous Cells of Undetermined Significance

S. Wacholder, M. Schiffman, D. Solomon, 2007, Obstetrics and gynecology.

74 – Cervical Cancer Screening

M. Schiffman, D. Solomon, 2000 .

Impact of human papillomavirus vaccination on cervical cytology screening, colposcopy, and treatment.

S. Wacholder, D. Solomon, A. Hildesheim, 2013, American Journal of Epidemiology.

The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses: developed and approved at the National Cancer Institute Workshop in Bethesda, Maryland, December 12-13, 1988.

D. Solomon, 1990, Human pathology.

Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials

George Macones, Diane Solomon, Allan Hildesheim, 2010, BMJ : British Medical Journal.

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.

S. Rosenberg, D. Solomon, M. Lotze, 1988, The New England journal of medicine.

M. Schiffman, A. Moscicki, D. Solomon, 2012 .

Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors

M. Schiffman, M. Einstein, D. Solomon, 2013 .

M. Schiffman, A. Moscicki, D. Solomon, 2012, American journal of clinical pathology.

Risk Assessment to Guide the Prevention of Cervical Cancer

M. Schiffman, D. Solomon, P. Castle, 2008, Journal of lower genital tract disease.

Tumor-specific cytolysis by lymphocytes infiltrating human melanomas.

S. Rosenberg, D. Solomon, S. Topalian, 1989, Journal of immunology.

Comparison of human papillomavirus distribution in cytologic subgroups of low‐grade squamous intraepithelial lesion

M. Schiffman, D. Solomon, R. Zuna, 2006, Cancer.

Does the interval between papanicolaou tests influence the quality of cytology?

M. Schiffman, D. Solomon, Michelle J. Khan, 2005, Cancer.

Terminology: IAC task force summary

D. Solomon, A. Herbert, Gupta Sk, 1998 .

Proposed guidelines for primary screening instruments for gynecologic cytology

P. Saigo, I. Ramzy, S. Raab, 1998, American journal of clinical pathology.

The Bethesda System for Reporting Cervical Cytology

D. Solomon, R. Nayar, D. Wilbur, 2004 .

Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine

D. Lowy, S. Wacholder, M. Sherman, 2011, Journal of the National Cancer Institute.

A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia.

R. DeSalle, S. Wacholder, Kai Yu, 2010, Cancer research.

74 – Cervical Cancer Screening

M. Schiffman, D. Solomon, 2000 .

Clinical practice. Cervical-cancer screening with human papillomavirus and cytologic cotesting.

M. Schiffman, D. Solomon, 2013, The New England journal of medicine.

Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia–Grade 2

M. Schiffman, D. Solomon, P. Castle, 2009, Obstetrics and gynecology.

Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma

D. Solomon, M. D. de Smet, D. Kohler, 1999, The British journal of ophthalmology.

Determinants of seropositivity among HPV-16/18 DNA positive young women

S. Wacholder, D. Solomon, A. Hildesheim, 2010, BMC infectious diseases.

Predicting the effect of successful human papillomavirus vaccination on existing cervical cancer prevention programs in the United States

M. Schiffman, D. Solomon, D. Saslow, 2008, Cancer.

Factors Influencing Histologic Confirmation of High-Grade Squamous Intraepithelial Lesion Cytology

M. Schiffman, D. Solomon, P. Castle, 2008, Obstetrics and gynecology.

The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses: Definitions, Criteria, and Explanatory Notes for Terminology and Specimen Adequacy

D. Solomon, R. Kurman, 1994 .

Findings From ALTS: Impact on Cervical Cytology Screening, Triage, and Patient Management

D. Solomon, P. Castle, 2005 .

Comparison of Measurements of Human Papillomavirus Persistence for Postcolposcopic Surveillance for Cervical Precancerous Lesions

M. Schiffman, D. Solomon, P. Castle, 2010, Cancer Epidemiology, Biomarkers & Prevention.